BiotechTube
Enable Medicine

Enable Medicine

San Francisco, United States· Est.
enablemedicine.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $6M

Overview

Enable Medicine is a private, AI-driven digital health company founded in 2019, operating as a platform and services provider in the biotech sector. The company has developed a comprehensive cloud platform that indexes and analyzes vast amounts of multimodal biological data, such as spatial proteomics and single-cell data, to answer critical research questions in areas like patient stratification and target identification. It collaborates with over 200 entities in biopharma and academia, has indexed data from 60,000+ samples, and has been featured in 75+ published studies. Enable Medicine is in an early revenue stage, monetizing its AI-powered analysis platform and scientific services to accelerate therapeutic R&D for its partners.

AutoimmuneOncologyInflammatory Diseases

Technology Platform

AI-powered cloud platform for indexing, analyzing, and searching multimodal biological data (e.g., spatial proteomics, single-cell data). Uses geometric deep learning and AI to create integrated biological atlases and generate actionable insights for drug R&D.

Funding History

1
Total raised:$6M
Seed$6M

Opportunities

The rapid growth of complex spatial and single-cell biology data creates a large, unmet need for advanced AI-driven interpretation tools.
Enable Medicine's platform-agnostic approach allows it to address a wide market across therapeutic areas and partner types, from academia to large pharma.
Successful demonstrations in high-impact publications can drive further adoption and establish the company as a standard tool in translational research.

Risk Factors

Intense competition from other AI/ML bioinformatics startups and established life science software vendors.
Challenges in scaling a service-heavy model and convincing risk-averse biopharma clients to outsource core data analysis.
Dependency on continuous technological innovation to stay ahead in a fast-evolving field.

Competitive Landscape

Enable Medicine competes in the broad AI-for-drug-discovery market, facing competition from pure-play software companies (e.g., Recursion, Insitro, Exscientia's platform efforts), large cloud providers (Google Cloud Life Sciences, AWS HealthOmics), and informatics vendors adding AI features. Its specific focus on integrated, searchable multimodal atlases and spatial biology may differentiate it from competitors with narrower data type or application focus.

More companies in AI / Machine Learning →More companies in United States →